東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Vitamin D receptor gene polymorphism...

Torkko, Kathleen Carroll.

FindBook

Google Book

Amazon

博客來

Vitamin D receptor gene polymorphisms and prostate cancer.

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Vitamin D receptor gene polymorphisms and prostate cancer./
作者:	Torkko, Kathleen Carroll.
面頁冊數:	123 p.
附註:	Adviser: John Hokanson.
Contained By:	Dissertation Abstracts International66-03B.
標題:	Biology, Genetics. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3168667
ISBN:	9780542050749

Vitamin D receptor gene polymorphisms and prostate cancer.
Torkko, Kathleen Carroll.

Vitamin D receptor gene polymorphisms and prostate cancer. - 123 p.

Adviser: John Hokanson.

Thesis (Ph.D.)--University of Colorado Health Sciences Center, 2005.

The biologic activity of vitamin D, mediated by the vitamin D receptor (VDR), may affect risk of prostate cancer (PCa) onset and progression. This genetic association study looked at relationships between PCa and VDR gene polymorphisms and haplotypes in a multi-ethnic cohort [non-Hispanic White (NHW), Hispanic White (HW), and African American (AA)]. Seven polymorphisms (CDX2, FokI, BsmI, Tru9I, ApaI, TaqI, a Poly-A repeat) were genotyped in 482 cases and 1,005 controls (60% NHW, 26% HW, 14% AA) from south Texas. Cases had biopsy-confirmed PCa; controls had normal screening exams (PSA < 2.5 ng/ml). Associations were found between PCa and BsmI, ApaI, and TaqI, but only in HW men heterozygous for the risk allele. HW men, however, with the CDX2 GG genotype had more than twice the risk for higher Gleason scores (vs. AG/AA, OR = 2.33, 1.23, 4.42). Common haplotypes were determined using standard linkage disequilibrium techniques. Risk haplotypes were estimated at the individual level using men homozygous for each of the haplotype alleles. The 3' end BsmI, Tru9I, ApaI, Taq I, and Poly-A (HA1) haplotype was inversely associated with PCa among HW men (OR = 0.49, 95%CI: 0.27, 0.89). The HB1 haplotype, that adds CDX2 to HA1, was inversely associated with cancer in NEW men (OR = 0.57, 0.38, 0.86). Gleason score is an important predictor of PCa progression. In NHW men, both haplotypes were inversely associated with higher Gleason scores (OR = 0.68, 0.47, 0.99; OR = 0.53, 0.34, 0.83, for H A1 and HB1, respectively). Interactions were found with FokI and the V89L polymorphism in the SRD5A2, a gene involved with testosterone metabolism. FokI alone was not associated with PCa. When stratified by V89L VV genotype, Fok I (TT/CT vs. CC) was associated with almost twice the risk for PCa (OR = 1.91, 1.21, 3.01). The inverse association of the H B1 haplotype was further strengthened in the V89L LL/LV genotypes. This thesis demonstrated that characterizing VDR haplotypes may add substantially to the approach of assessing genetic polymorphisms in the investigation of genetic risk for PCa, cancer progression, and interactions with other genes. The association of VDR polymorphisms with PCa may be better understood when examined together with genes along related risk pathways.

ISBN: 9780542050749Subjects--Topical Terms:

1017730
Biology, Genetics.

Vitamin D receptor gene polymorphisms and prostate cancer.
LDR:03241nam 2200313 a 45 001 972828
005 20110928
008 110928s2005 eng d
020 $a 9780542050749
035 $a (UnM)AAI3168667
035 $a AAI3168667
040 $a UnM $c UnM
100 1 $a Torkko, Kathleen Carroll. $3 1296797
245 1 0 $a Vitamin D receptor gene polymorphisms and prostate cancer.
300 $a 123 p.
500 $a Adviser: John Hokanson.
500 $a Source: Dissertation Abstracts International, Volume: 66-03, Section: B, page: 1370.
502 $a Thesis (Ph.D.)--University of Colorado Health Sciences Center, 2005.
520 $a The biologic activity of vitamin D, mediated by the vitamin D receptor (VDR), may affect risk of prostate cancer (PCa) onset and progression. This genetic association study looked at relationships between PCa and VDR gene polymorphisms and haplotypes in a multi-ethnic cohort [non-Hispanic White (NHW), Hispanic White (HW), and African American (AA)]. Seven polymorphisms (CDX2, FokI, BsmI, Tru9I, ApaI, TaqI, a Poly-A repeat) were genotyped in 482 cases and 1,005 controls (60% NHW, 26% HW, 14% AA) from south Texas. Cases had biopsy-confirmed PCa; controls had normal screening exams (PSA < 2.5 ng/ml). Associations were found between PCa and BsmI, ApaI, and TaqI, but only in HW men heterozygous for the risk allele. HW men, however, with the CDX2 GG genotype had more than twice the risk for higher Gleason scores (vs. AG/AA, OR = 2.33, 1.23, 4.42). Common haplotypes were determined using standard linkage disequilibrium techniques. Risk haplotypes were estimated at the individual level using men homozygous for each of the haplotype alleles. The 3' end BsmI, Tru9I, ApaI, Taq I, and Poly-A (HA1) haplotype was inversely associated with PCa among HW men (OR = 0.49, 95%CI: 0.27, 0.89). The HB1 haplotype, that adds CDX2 to HA1, was inversely associated with cancer in NEW men (OR = 0.57, 0.38, 0.86). Gleason score is an important predictor of PCa progression. In NHW men, both haplotypes were inversely associated with higher Gleason scores (OR = 0.68, 0.47, 0.99; OR = 0.53, 0.34, 0.83, for H A1 and HB1, respectively). Interactions were found with FokI and the V89L polymorphism in the SRD5A2, a gene involved with testosterone metabolism. FokI alone was not associated with PCa. When stratified by V89L VV genotype, Fok I (TT/CT vs. CC) was associated with almost twice the risk for PCa (OR = 1.91, 1.21, 3.01). The inverse association of the H B1 haplotype was further strengthened in the V89L LL/LV genotypes. This thesis demonstrated that characterizing VDR haplotypes may add substantially to the approach of assessing genetic polymorphisms in the investigation of genetic risk for PCa, cancer progression, and interactions with other genes. The association of VDR polymorphisms with PCa may be better understood when examined together with genes along related risk pathways.
590 $a School code: 0831.
650 4 $a Biology, Genetics. $3 1017730
650 4 $a Health Sciences, General. $3 1017817
650 4 $a Health Sciences, Medicine and Surgery. $3 1017756
650 4 $a Health Sciences, Oncology. $3 1018566
650 4 $a Health Sciences, Pathology. $3 1017854
690 $a 0369
690 $a 0564
690 $a 0566
690 $a 0571
690 $a 0992
710 2 0 $a University of Colorado Health Sciences Center. $3 1023815
773 0 $t Dissertation Abstracts International $g 66-03B.
790 $a 0831
790 1 0 $a Hokanson, John, $e advisor
791 $a Ph.D.
792 $a 2005
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3168667